Poor countries to get new AIDS pill

Jul 06, 2006

A new 3-in-1 AIDS pill made in India and approved by U.S. drug regulators is expected to treat patients in poor countries.

The pill made by an Indian generic drug company is the first such antiretroviral treatment approved by the Food and Drug for patients in countries helped by the President's Emergency Plan for AIDS Relief, reports The New York Times.

Dr. Mark R. Dybul, the White House global AIDS coordinator, said the new pill should greatly improve treatment for patients in poor countries.

Under a White House plan, the United States has become the largest provider of antiretroviral drugs in the world. The plan helps treat some 561,000 patients in Africa, Asia and the Caribbean, the Times reported.

The new pill, made by Aurobindo Pharma of Hyderabad, India, combines three common first-line drugs, AZT, 3TC and NVP, which are sold in the United States as Retrovir, Epivir and Viramune, the report said.

Copyright 2006 by United Press International

Explore further: Outpatient uterine polypectomy more cost-effective

Related Stories

EPA says first day of oil spill spent 'planning'

7 hours ago

On the afternoon of the largest coastal oil spill in California in 25 years, graduate student Natalie Phares quickly organized a volunteer bucket brigade to clean a beach north of Santa Barbara.

Insect mating behavior has lessons for drones

7 hours ago

Male moths locate females by navigating along the latter's pheromone (odor) plume, often flying hundreds of meters to do so. Two strategies are involved to accomplish this: males must find the outer envelope ...

Recommended for you

Outpatient uterine polypectomy more cost-effective

5 hours ago

(HealthDay)—For women with abnormal uterine bleeding and hysteroscopically diagnosed endometrial polyps, outpatient treatment is more cost-effective than inpatient treatment, according to research published ...

Rapamune approved for rare lung disease

6 hours ago

(HealthDay)—Rapamune (sirolimus) has been approved by the U.S. Food and Drug Administration to treat a rare, progressive lung disease that mostly affects women of childbearing age.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.